Overview: Zynerba Pharmaceuticals is a company developing cannabinoid therapies for rare and near-rare neuropsychiatric conditions. The company’s leading drug candidate is a pharmaceutical-grade transdermal CBD gel. Its transdermal CBD gel, called Zygel, is undergoing late-stage clinical trials testing its safety...

You must subscribe to Danny Brody’s Cannabis Inner Circle to view this content. To learn more and access special member pricing contact our VIP team at 1-866-298-7257. 

Sign In

Enter your details below.